Journal
JOURNAL OF IMMUNOLOGY
Volume 185, Issue 12, Pages 7165-7173Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.0902583
Keywords
-
Categories
Funding
- Centre National de la Recherche Scientifique
Ask authors/readers for more resources
Progressing tumors in humans and mice are frequently infiltrated by a highly heterogeneous population of inflammatory myeloid-cells that contribute to tumor growth. Among these cells, inflammatory Gr-1(+) monocytes display a high developmental plasticity in response to specific microenvironmental signals, leading to diverse immune functions. These observations raise the question of the immune mechanisms by which inflammatory monocytes may contribute to tumor development. In this study, we found that adoptive transfer of normal inflammatory Gr-1(+) monocytes in tumor-bearing mice promotes tumor growth. In this tumoral environment, these monocytes can differentiate into tolerogenic dendritic cells ( DCs) that produce IL-10 and potently induce regulatory T cell responses in vivo. Moreover, diverting the differentiation of Gr-1(+) monocytes into tolerogenic DCs by forced expression of IL-10 soluble receptor and IL-3 in tumor cells improves host immunosurveillance by reducing the regulatory T cell frequency and by inducing immunogenic DCs in the tumor. As a consequence, tumor growth is strongly reduced. Our findings indicate that Gr-1(+) monocytes represent a valuable target for innovative immunotherapeutic strategies against cancer. The Journal of Immunology, 2010, 185: 7165-7173.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available